HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial

Robert E Booth, Jonathan M Davis, Sergey Dvoryak, John T Brewster, Oksana Lisovska, Steffanie A Strathdee, Carl A Latkin, Robert E Booth, Jonathan M Davis, Sergey Dvoryak, John T Brewster, Oksana Lisovska, Steffanie A Strathdee, Carl A Latkin

Abstract

Background: HIV prevalence among people who inject drugs (PWID) in Ukraine is among the highest in the world. In this study, we aimed to assess whether a social network intervention was superior to HIV testing and counselling in affecting HIV incidence among PWID. Although this was not the primary aim of the study, it is associated with reducing drug and sex risk behaviours, which were primary aims.

Methods: In this clustered randomised trial, PWID who were 16 years of age or older, had used self-reported drug injection in the past 30 days, were willing to be interviewed for about 1 hour and tested for HIV, were not too impaired to comprehend and provide informed consent, and, for this paper, who tested HIV negative at baseline were recruited from the streets by project outreach workers in three cities in southern and eastern Ukraine: Odessa, Donetsk, and Nikolayev. Index or peer leaders, along with two of their network members, were randomly assigned (1:1) by the study statistician to the testing and counselling block (control group) or the testing and counselling plus a social network intervention block (intervention group). No stratification or minimisation was done. Participants in the network intervention received five sessions to train their network members in risk reduction. Those participants assigned to the control group received no further intervention after counselling. The main outcome of this study was HIV seroconversion in the intent-to-treat population as estimated with Cox regression and incorporating a γ frailty term to account for clustering. This trial is registered with ClinicalTrial.gov, number NCT01159704.

Findings: Between July 12, 2010, and Nov 23, 2012, 2304 PWIDs were recruited, 1200 of whom were HIV negative and are included in the present study. 589 index or peer leaders were randomly assigned to the control group and 611 were assigned to the intervention group. Of the 1200 HIV-negative participants, 1085 (90%) were retained at 12 months. In 553·0 person-years in the intervention group, 102 participants had seroconversion (incidence density 18·45 per 100 person-years; 95% CI 14·87-22·03); in 497·1 person-years in the control group 158 participants seroconverted (31·78 per 100 person-years; 26·83-36·74). This corresponded to a reduced hazard in the intervention group (hazard ratio 0·53, 95% CI 0·38-0·76, p=0·0003). No study-related adverse events were reported.

Interpretation: These data provide strong support for integrating peer education into comprehensive HIV prevention programmes for PWID and suggest the value in developing and testing peer-led interventions to improve access and adherence to pre-exposure prophylaxis and antiretroviral therapy.

Funding: The National Institute on Drug Abuse.

Conflict of interest statement

Declaration of interests We declare that we have no conflicts of interests.

Copyright © 2016 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1

References

    1. UNAIDS Fact Sheet. [Accessed from April 5, 2015];2014 .
    1. World Health Organization. The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec. 1995;70:355.
    1. Khodakevich L, Dehne K. Inaugural Meeting of the Global Research Network on HIV Prevention in Drug-Using Populations. Geneva: 1998. Jun, HIV epidemics in drug using populations and increasing drug use in central and Eastern Europe.
    1. WHO, UNAIDS, UNICEF. Monitoring and reporting on the health sector response to HIV/AIDS; Ukraine country report 2012. Geneva: World Health Organization; 2012.
    1. HIV infection in Ukraine Informational Bulletin. Issue 43. Kyiv: Ministry of Health of Ukraine, Ukrainian Center for Socially Dangerous Diseases Control, Gromashevsky Institute of Epidemiology and Infectious Diseases. 2015
    1. Ministry of Health Ukraine. HIV-infection in Ukraine: Information Bulletin no. 27. Ministry of Health Ukraine, Ukrainian AIDS Centre, L.V. Gromashevskogo; 2007.
    1. UNAIDS/WHO. Joint United Nations Programme on HIV/AIDS: AIDS epidemic update. Geneva, Switzerland: 2002. Dec,
    1. Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP. The most severe HIV epidemic in Europe: Ukrain’s national prevalence for 2007. Sex Transm. Infect. 2008;84(Suppl 1):i37–i41.
    1. UNAIDS. AIDS Epidemic Update: November 2009. New York: UNAIDS; 2010.
    1. Vitek CR, Cakalo JI, Kruglov YV, Dumchev KV, Salyuk TO, Bozicevic I, et al. Slowing of the HIV epidemic in Ukraine: Evidence from case reporting and Key Population Surveys, 2005–2012. PloS one. 2014;9(9):e103657.
    1. International HIV/AIDS Alliance in Ukraine. Summary of the Analytical Report: Monitoring the Behavior and HIV-Infection Prevalence among People Who Inject Drugs as a Component of the HIV Second Generation Surveillance. 2014
    1. Booth RE, Kennedy JK, Brewster JT, Semerik O. Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs. 2003;35:419–426.
    1. Booth RE, Lehman WE, Latkin CA, Brewster JT, Sinitsyna, Dvoryak S. Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in Ukraine. Journal of Drug Issues. 2009 Spring;:1945–1962.
    1. Booth RE, Lehman WE, Latkin CS, Dvoryak S, Brewster JT, Royer MS, Sinitsyna L. Individual and network interventions with injection drug users in five Ukraine cities. American Journal of Public Health. 2011;101:336–343.
    1. Latkin CA, Mandell W, Oziemkowska M, Vlahov D, Celentano DA. The relationship between sexual behavior, alcohol use, and personal network characteristics among injection drug users in Baltimore, MD. JAIDS. 1994;13:273–280.
    1. Friedman SR, Kottiri BJ, Neaigus A, Curtis R, Vermund SH, Des Jarlais DC. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population group saturation. American Journal of Epidemiology. 2000;152:913–922.
    1. Latkin CA. Outreach in natural setting: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Reports. 1998;113:151–159.
    1. Latkin CA, Knowlton AR. New directions in HIV prevention among drug users - settings, norms, and pproaches to AIDS prevention (SNNAAP): a social influence approach. Advances in Medical Sociology. 2000;7:261–287.
    1. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long term outcomes of a personal network-oriented intervention for injecting drug users: the SAFE Study. American Journal of Community Psychology. 1996;24:341–365.
    1. Carlson R, Wang J, Siegal H, Falck R, Guo J. An Ethnographic Approach to Targeted Sampling: Problems and Solutions in AIDS Prevention Research among Injection Drug and Crack-Cocaine Users. Hum. Organ. 1994;53:279–286.
    1. Wiebel W. Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. In: Battjes RJ, Pick RW, editors. Needle Shar. Intraven. Drug Users Natl. Int. Perspect. Washington, D.C: US Printing Office; 1998. pp. 137–150.
    1. Dowling-Guyer S, Others A. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1:383–392.
    1. Weatherby N, Needle R, Cesar H, Booth R, McCoy C, Watters J, et al. Validity of self-reported drug use among injection drug users and crack smokers recruited through street outreach. 1994:347–355.
    1. Coyle SL. The NIDA HIV Counseling and Education Intervention Manual. Rockville, MD: National Institute on Drug Abuse; 1993.
    1. Booth RE, Lehman WE, Dvoryak S, Brewster JT, Sinitsyna L. Interventions with injection drug users in Ukraine. Addiction. 2009;104:1864–1873.
    1. Booth RE, Kwiatkowski CF, Stephens RC. Effectiveness of HIV/AIDS interventions for out-of-treatment injection drug users. Journal of Psychoactive Drugs. 1998b;30:269–278. PMID:9798793.
    1. Stephens RC, Kwiatkowski CF, Booth RE. The impact of the NIDA Cooperative Agreement programs among crack and injection drug users. In: Levy JA, Stephens RC, McBride DC, editors. Advances in Medical Sociology. Stamford, CT: JAI Press; 2000. pp. 241–259.
    1. Booth RE, Lehman WE, Kwiatkowski CF, Brewster JT, Sinitsyna, Dvoryak S. Stimulant injectors in Ukraine: the next wave of the epidemic? AIDS and Behav. 2008;12:652–661.
    1. Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV serostatus among drug injectors at three Ukraine sites. AIDS. 2006;20:1–7.
    1. Booth RE, Kwiatkowski CF, Mikulich-Gilbertson, Brewster JT, Salomsonsen-Sautel S, Corsi KF, Sinitsyna L. Predictors of risky needle use following interventions with drug injectors in Ukraine. Drug and Alcohol Dependence. 2006:S49–S57.
    1. Hoffman IF, Latkin CA, Kukhareva PV, Malov SV, Batluk JV, Shaboltas AV, Skochilov RV, Sokolov NV, Verevochkin SV, Hudgens MG, Kozlov AP. A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia. AIDS Behav. 2013 Sep;17(7):2510–2520. PubMed PMID: 23881187; PubMed Central PMCID: PMC3950300.
    1. Mihailovic A, Tobin K, Latkin C. The Influence of a Peer-Based HIV Prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland. AIDS Behav. 2015 Apr 7; [Epub ahead of print] PubMed PMID: 25845530.
    1. Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011 Feb;106(2):366–375. Epub 2010 Nov 4. PubMed PMID: 21054614; PubMed Central PMCID: PMC3049994.
    1. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003 Jul;22(4):332–339. PubMed PMID: 12940388.
    1. Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, Quan VM, Gandham S, Vongchak T, Perdue T, Celentano DD. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009 Feb;68(4):740–748. Epub 2008 Dec 13. PubMed PMID: 19070413; PubMed Central PMCID: PMC2724962.
    1. Booth RE, Mikulich-Gilbertson SK, Brewster JT, Salomonson-Sautel S, Semerik O. Predictors of self-reported HIV infection among drug injectors in Ukraine. JAIDS. 2004;35:82–88.
    1. Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV serostatus among drug injectors at three Ukraine sites. AIDS. 2006;20:1–7.
    1. Booth RE, Davis JM, Brewster JT, Lisovska O, Dvoryak S. Krokodile injectors in Ukraine: Fueling the epidemic? AIDS and Behav. 2016;20:369–376.
    1. Maisto S, McKay J, Conners G. Self-reported issues in substance abuse: state of the art and future directions. Behav Assess. 1990;121:117–134.
    1. Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996;42:11–20.
    1. Vitek CR, Cakalo J-I, Kruglov YV, Dumchev KV, Salyuk TO, Bozicevic I, et al. Slowing of the HIV epidemic in Ukraine: Evidence from case reporting and key population surveys, 2005 – 2012. PLOS ONE. 2014 Sep;9(9):e103657.
    1. Cakalo J-I, Bozicevic I, Vitek C, Mandel JS, Salyuk T, Rutherford GW. Misclassification of men with reported HIV infection in Ukraine. AIDS Behav. Published online DOI 10.1007/s10461-015-112-0: June 13, 2015.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi